Cargando…
Repeated trans-arterial treatments of LDL-DHA nanoparticles induce multiple pathways of tumor cell death in hepatocellular carcinoma bearing rats
INTRODUCTION: Repeated hepatic arterial delivery of therapeutic agents to the liver by percutaneously implanted port-catheter systems has been widely used to treat unresectable liver cancer. This approach is applied to assess the therapeutic efficacy of repeated low-density lipoprotein-docosahexaeno...
Autores principales: | Wang, Yuzhu, Li, Junjie, do Vale, Goncalo Dias, Chaudhary, Jaideep, Anwar, Arnida, McDonald, Jeffrey G., Qin, Tao, Zhang, Hongwei, Corbin, Ian R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730405/ https://www.ncbi.nlm.nih.gov/pubmed/36505796 http://dx.doi.org/10.3389/fonc.2022.1052221 |
Ejemplares similares
-
Interplay between Asters/GRAMD1s and phosphatidylserine in intermembrane transport of LDL cholesterol
por: Trinh, Michael N., et al.
Publicado: (2022) -
Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
por: Park, Yehyun, et al.
Publicado: (2019) -
Soluble Polyimides Bearing (cis, trans)-Hydrogenated Bisphenol A and (trans, trans)-Hydrogenated Bisphenol A Moieties: Synthesis, Properties and the Conformational Effect
por: Mi, Zhiming, et al.
Publicado: (2019) -
Last step in the path of LDL cholesterol from lysosome to plasma membrane to ER is governed by phosphatidylserine
por: Trinh, Michael N., et al.
Publicado: (2020) -
Lipoprotein Drug Delivery Vehicles for Cancer: Rationale and Reason
por: Chaudhary, Jaideep, et al.
Publicado: (2019)